Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study using national population data

BACKGROUND: Studies have reported evidence about the effectiveness of a third dose with BNT162b2 for preventing hospitalization and death by COVID-19. However, there is little evidence regarding other primary vaccine schedules such as BBIBP-CorV and ChAdOx1-S. We estimated the relative vaccine effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva-Valencia, Javier, Soto-Becerra, Percy, Escobar-Agreda, Stefan, Fernandez-Navarro, Manuel, Elorreaga, Oliver A., Mayta-Tristán, Percy, Mezones-Holguin, Edward, Solari, Lely
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515342/
https://www.ncbi.nlm.nih.gov/pubmed/36202642
http://dx.doi.org/10.1016/j.vaccine.2022.09.066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515342/
https://www.ncbi.nlm.nih.gov/pubmed/36202642
http://dx.doi.org/10.1016/j.vaccine.2022.09.066

Ejemplares similares